Pancreatic Neuroendocrine Tumor trials recruiting in Tennessee

Fewer than 3 recruiting trials found.

All Pancreatic Neuroendocrine Tumor trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
  NCT04924075 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · Tennessee: Nashville
• Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
  NCT05040360 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Alcoa, Collierville, Knoxville, Memphis